TG THERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 179894000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d3bf52e7-995b-4692-9f39-5751747fba22
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-25-005908Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/cash-and-equivalents/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d3bf52e7-995b-4692-9f39-5751747fba22
History
- no predecessors — first report